<DOC>
	<DOCNO>NCT02350842</DOCNO>
	<brief_summary>Cardiac resynchronization recommend therapy patient advance heart failure , optimize medical treatment reduce leave ventricular ejection fraction prolong QRS , nevertheless , still 30 % population respond standard biventricular implantation . Non-response explained combination factor include sub-optimal patient selection , placement pace lead zone slow conduction , insufficient correction mechanical dyssynchrony include sub-optimal lead implantation . Few data distinguish true non-responders patient effective resynchronization deliver standard biventricular implantation . Triple-site cardiac resynchronization pacing ( stimulation three ventricular site ) propose improve synchrony thus response rate ( Cardiac Resynchronisation Therapy ) CRT recipient .</brief_summary>
	<brief_title>Triple-site Biventricular Stimulation Optimization CRT</brief_title>
	<detailed_description>The frequent failure CRT non-Left Bundle Branch Block ( non-LBBB ) patient suspect due complex heterogeneous form electrical/mechanical dyssynchronies need complex individualize pacing configuration correct . Acute study implant show standard biventricular pacing provide optimal mechanical improvement minority patient . In peri-operative echo-guided lead placement procedure non-improved patient could successfully mechanically resynchronized . A significant number patient required optimized placement right ventricular ( RV ) lead and/or triple-site configuration . These study lead hypothesis complex individualize pace configuration ( Triple-site biventricular ) might increase number responder CRT . To assess hypothesis , study conduct Class II-ambulatory IV patient indicate CRT wide QRS ( ≥ 140 m ) non-LBBB . Patients randomize 1:1 configuration : - Standard biventricular pacing ( 1 right ventricular/1 leave ventricular ( 1RV/1LV ) ) classical implantation procedure without peri-operative optimization - Triple-site biventricular pace individual optimization placement third lead peri-operative echo guidance . The objective optimization process improve LV efficiency decrease leave pre-ejection interval ( LPEI , define time interval onset QRS onset LV ejection ) much possible compare standard biventricular configuration move second right ventricular lead different location . LPEI simple measure , good inter- intra-observer reproducibility utility previously strongly suggest . Reduction LPEI result decrease duration ventricular systole associate improved LV filling reduce interventricular delay . The primary objective study demonstrate individually optimize , triple-site biventricular pace superior standard biventricular pace reverse ventricular modeling demonstrate Echo Left Ventricle End-Systolic Volume ( LVESV ) 1 year patient non-LBBB morphology without increase risk serious procedure and/or device related adverse event 30 day .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Age &gt; 18 year Stable heart failure New York Heart Association ( NYHA ) functional class II , III ambulatory IV Stable optimize medical regimen accord medical guideline ( No change heart failure medication least 1 month prior enrollment ) Left ventricular ejection fraction ( LVEF ) ≤ 35 % Intrinsic QRS duration ≥ 140 msec Nontypical leave bundle branch block ( LBBB ) morphology 12lead surface ECG Signed date informed consent Typical LBBB accord Strauss criterion Unstable heart failure Permanent longlasting persistent Atrial Fibrillation Unstable angina , acute Myocardial Infarction ( MI ) , Coronary Artery BypassGrafting ( CABG ) , Percutaneous Transluminal Coronary Angioplasty ( PTCA ) within 90 day prior enrollment ( intervention ) Conventional pacemaker indication Previous implant pacemaker Implantable CardioverterDefibrillator ( ICD ) Renal Failure ( Glomerular filtration rate ( GFR ) &lt; 30 ml/min/1.73m2 ) Pregnant woman Already include another clinical study could confound result study Life expectancy &lt; 12 month Mechanical heart valve indication valve repair replacement Recent CerebroVascular Accident ( CVA ) Transient Ischemic Attack ( TIA ) ( within previous 3 month ) Heart transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>non-Left Bundle Branch Block morphology</keyword>
	<keyword>Triple-site biventricular pacing</keyword>
	<keyword>cardiac resynchronization therapy</keyword>
</DOC>